Outline
DOI: 10.1200/op.23.00224 ISSN:
Changing Tides? Anticancer Biologic and Biosimilar Use in Medicare Part B, 2019-2021
Alison R. McClean, Anita K. Wagner, Christine Y. Lu- Oncology (nursing)
- Health Policy
- Oncology
Anticancer biosimilar use is rising but significant potential savings remain unrealized @alison_mcclean @ChrisLuPhD
More from our Archive
- DOI: 10.1097/spc.0000000000000672 2023Goals of care and end-of-life communication needs of persons with chronic respiratory diseaseLynn F. Reinke, Tracy Fasolino, Donald R. Sullivan
- DOI: 10.1200/op.22.00846 2023Burnout and Appreciation: A Cross-Sectional Study Assessing Preferences for Appreciation Among Oncology CliniciansDoerte Heimbeck, Laurence R. Gore, Jennifer L. Bickel-Young
- DOI: 10.1200/op.23.00159 2023Defining Priorities in Value-Based Cancer Care: Insights From the Alliance for Clinical Trials in Oncology National Cooperative Group SurveyCasey J. Allen, Rebecca A. Snyder, Danea Marie Horn, Matthew F. Hudson, Anne Barber, Fabrice Smieliauskas, Patty A. Spears, Stephen Edge, Rachel A. Greenup
- DOI: 10.1200/op.23.00021 2023Real-World Use of Positron Emission Tomography-Computed Tomography and Reported Deauville Scores in Advanced-Stage Classic Hodgkin Lymphoma: A Community Oncology Practice PerspectiveChristopher Yasenchak, Nicholas Liu, April Beeks, Michelle Fanale, Nicholas Robert, Ding He, Kristina S. Yu
- DOI: 10.1200/op.23.00044 2023Ethical Considerations of Biopsies in Early-Stage Pancreatic CancerRiley P. Bohan, Andrea N. Riner, Kelly M. Herremans, Thomas J. George, Steven J. Hughes, Lauren B. Solberg
- DOI: 10.1097/spc.0000000000000671 2023Home ventilation for patients with end-stage chronic obstructive pulmonary diseaseTim Raveling, Heidi A. Rantala, Marieke L. Duiverman
- DOI: 10.1200/op.23.00185 2023Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data QualityJoseph M. Unger, Hillary Stires, Laura A. Levit, Mark Stewart, Brittany Avin McKelvey, Beverly Canin, Emily Dressler, Keith Flaherty, Peter Fredette, Lee Jones, Peggy McCann, Therica Miller, Adedayo A. Onitilo, Fran Palmieri, Timil Patel, Rocio Paul, Gary L. Smith, Suanna S. Bruinooge, Elizabeth Garrett-Mayer, Xiudong Jennifer Lei, Ajjai Alva, Caroline Schenkel
- DOI: 10.1200/op.23.00224 2023Changing Tides? Anticancer Biologic and Biosimilar Use in Medicare Part B, 2019-2021Alison R. McClean, Anita K. Wagner, Christine Y. Lu
- DOI: 10.1200/op.23.00059 2023Prevalence and Risk Factors for Moral Distress in Pediatric Oncology Health Care ProfessionalsNatalie Mathews, Khalid Alodan, Nathan Kuehne, Kimberley Widger, Maria Locke, Karen Fung, Sheila Gandhi, Jennifer McLean, Alomgir Hossain, Sarah Alexander
- DOI: 10.1200/op.22.00829 2023Relationships Among Health Insurance Literacy, Financial Toxicity, and Sociodemographic Factors in Patients With CancerMinji K. Lee, Urshila Durani, Nan Zhang, Talal Hilal, Rahma M. Warsame, Bijan Borah, Nandita Khera, Joan M. Griffin